Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjunctive Withania Somnifera (Ashwagandha) for Persistent Symptoms in People With Schizophrenia

NCT03437668 is registered in ClinicalTrials.gov with Chengappa, K.N. Roy, MD as lead sponsor.

NCT NCT03437668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03437668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjunctive Withania Somnifera (Ashwagandha) for Persistent Symptoms in People With Schizophrenia
Lead sponsor
Chengappa, K.N. Roy, MD
Phase
Phase 2/3
Overall status
Terminated
Start date
December 1, 2018
Completion date
June 12, 2023
Enrollment
47 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia